Mobile health services provider DocGo has posted a net income of $4.6m in the third quarter of 2023 (Q3 2023), an 84% increase compared with $2.5m in the same period last year.

Basic net income per share attributable to DocGo and its subsidiaries reached $0.05 in the quarter, versus $0.03 in the previous year.

For the quarter ended 30 September 2023, the company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) stood at $13m.

This marked a 78.1% growth from $7.3m in the prior year.

Total revenues for the quarter amounted to $186.6m, a 79% rise from $104.3m in Q3 2022.

The growth was largely driven by higher Mobile Health Services revenues, which soared 82% to $139.3m in the quarter from $76.6m a year ago.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Transportation Services revenues increased 70% during the same period, to $47.2m from $27.7m.

Net income margin for Q3 2023 was 2.5%, compared with 2.4% last year.

DocGo’s backlog expanded to $430m, and it held $67.3m in cash and cash equivalents as of 30 September 2023 compared with $123.8m on 30 June 2023.

The company has now lifted its 2023 revenue outlook to $615-625m, from the prior range of $540-550m.

DocGo chief financial officer and treasurer Norm Rosenberg said: “As expected, we experienced significant earnings leverage in the third quarter due to our strong top-line growth. While we did experience higher costs associated with the aggressive ramp-up of new projects, we are encouraged by the net margin and adjusted EBITDA margin expansion we witnessed during the period and expect further improvements in Q4 and beyond. The decline in cash balance was driven by substantial receivables associated with the large HPD project under which payments have commenced.”